Form 10-Q · Quarterly report
Darden Restaurants 10-Q, filed Oct 2, 2026
- Filed
- CIK
- 0000940944
- Accession no.
- 0000940944-26-000042
Summary
Darden Restaurants reported first-quarter fiscal 2027 sales of $3.20 billion, up 5.1%, while net earnings fell 9.5% to $233.4 million and diluted net earnings per share from continuing operations were $2.05, down from $2.19 a year earlier. Darden expects fiscal 2027 sales of $13.60 billion to $13.75 billion, same-restaurant sales growth of 2.5% to 3.5%, 75 to 80 new restaurant openings, and capital expenditures of about $875 million.
Key points
- Total sales rose 5.1% to $3.20 billion in the quarter ended August 30, 2026, driven by 53 net new restaurants and a blended same-restaurant sales increase of 3.1%.
- Net earnings from continuing operations were $234.3 million, down from $257.9 million a year earlier, and diluted EPS from continuing operations was $2.05 versus $2.19.
- Darden operated 2,218 company-owned restaurants at August 30, 2026, including 953 Olive Garden and 624 LongHorn Steakhouse locations.
- Darden said it completed closing roughly half of Bahama Breeze restaurants in April 2026 and expects to convert the remaining locations to other Darden brands over 12–18 months.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations The following Management’s Discussion and Analysis, which contains forward-looking statements, should be read in conjunction with the unaudited consolidated financial statements and the notes to such financial statements included elsewhere in this quarterly report on Form 10-Q (“Form 10-Q”) and the audited consolidated financial statements and the notes thereto included in our Form 10-K for the fiscal year ended May 31, 2026 (“Form 10-K”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.